Guillermo Villacampa Javierre - Vall d'Hebron Institute of Oncology

基本信息

浏览量：1

职业迁徙

个人简介

G. Villacampa works as biostatistician in the Oncology Data Science group (OdysSey) at Vall d’Hebron Institute of Oncology (VHIO) and in SOLTI group. My main responsibilities in this role are: i) to perform data analysis in clinical research (mainly focus on survival modelling using R software); and ii) to provide guidance in clinical trial designs in oncology. I am a member of the Spanish Biometric Society (SEB), Catalan Statistics Society (SoCE) and Biostatnet.

研究兴趣

论文共 258 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Immunotherapy and PARP Inhibitors As First-Line Treatment in Endometrial Cancer: A Systematic Review and Network Meta-Analysis

Guillermo Villacampa,Gemma Eminowicz,Victor Navarro, Lorenzo Carità, David García-Illescas,Ana Oaknin,J Alejandro Pérez-Fidalgo

European journal of cancer (Oxford, England 1990) (2025): 115329-115329

引用0浏览0WOS引用

Adjuvant Endocrine Treatment Strategies for Non-Metastatic Breast Cancer: a Network Meta-Analysis

Andri Papakonstantinou,Guillermo Villacampa, Victor Navarro,Mafalda Oliveira,Antonios Valachis,Tomas Pascual,Alexios Matikas

EClinicalMedicine (2025): 103116-103116

引用0浏览0WOS引用

RAD51 Testing in Patients with Early HER2-Negative Breast Cancer and Homologous Recombination Deficiency: A Post Hoc Analysis of the GeparOLA Trial

Clinical cancer research an official journal of the American Association for Cancer Researchno. 5 (2025): 808-814

引用0浏览0WOS引用

HER2DX in HER2-positive Inflammatory Breast Cancer: Correlative Insights and Comparative Analysis with Noninflammatory Breast Cancers5

F. Lynce,O. Martinez-Saez,B. Walbaum,F. Braso-Maristany,A. G. Waks,P. Villagrasa,G. Villacampa Javierre,E. Sanfeliu, P. Galvan,L. Pare, L. M. Anderson,C. M. Perou, J. S. Parker, A. Vivancos, M. K. Dilullo,S. Pernas,E. P. Winer,B. Overmoyer,E. A. Mittendorf,C. Bueno-Muino, M. Martin,A. Prat,S. M. Tolaney

ESMO OPENno. 2 (2025)

引用0浏览0引用

HER2DX in HER2-positive Inflammatory Breast Cancer: Correlative Insights and Comparative Analysis with Noninflammatory Breast Cancers

F Lynce,O Martínez-Sáez,B Walbaum,F Brasó-Maristany,A G Waks,P Villagrasa,G Villacampa Javierre,E Sanfeliu, P Galván,L Paré, L M Anderson, C M Perou, J S Parker, A Vivancos, M K DiLullo,S Pernas, E P Winer,B Overmoyer, E A Mittendorf,C Bueno-Muiño, M Martín, A Prat, S M Tolaney

ESMO open（2025）

引用0浏览0WOS引用

Linking Tumor Immune Infiltration to Enhanced Longevity in Recurrence-Free Breast Cancer

L. Angelats,L. Pare, C. Rubio-Perez,E. Sanfeliu, A. Gonzalez,E. Segui,G. Villacampa, M. Marin-Aguilera,S. Pernas, B. Conte, V. Albarran-Fernandez,O. Martinez-Saez, A. Aguirre, P. Galvan, A. Fernandez-Martinez, S. Cobo, M. Rey, A. Martinez-Romero,B. Walbaum, F. Schettini, M. Vidal,W. Buckingham, M. Munoz, B. Adamo, Y. Agrawal,S. Guedan, T. Pascual, J. Agudo, M. Grzelak, N. Borcherding,H. Heyn, A. Vivancos, J. S. Parker,P. Villagrasa, C. M. Perou, A. Prat,F. Braso-Maristany

ESMO OPENno. 1 (2025)

引用0浏览0WOS引用

736P Exceptional Clinical Benefit (ECB) from Immune Checkpoint Inhibitors (icis) in Mismatch-Repair Deficient (mmrd) in Recurrent /metastatic Endometrial Cancer (r/mec): Are We Curing a Subset of MMRd EC Patients (Pts)

J.F. Grau Béjar, T. Guinel,R. Mazzeo,L. Musacchio,O. Le Saux, R. Sabatier, H. Salaun,L. Eberst,C. Garcia Duran, L. Carità,G. Villacampa, J-S. Frenel,G. Scambia,I. Ray-Coquard,D. Lorusso,A. Oaknin, A. Leary

Annals of Oncology (2024): S560-S560

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn